BenchSci

About:

BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.

Twitter/X: benchsci

Top Investors: F-Prime Capital, Creative Destruction Lab (CDL), Radical Ventures, Inovia Capital, Northleaf Capital Partners

Description:

BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery. The company empowers scientists with advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, BenchSci's proprietary technology accelerates science pharmaceutical companies and over 4,300 research centers worldwide.

Total Funding Amount:

$164M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2015-01-01

Contact Email:

support(AT)benchsci.com

Founders:

David Qixiang Chen, Elvis Wianda, Liran Belenzon, Tom Leung

Number of Employees:

251-500

Last Funding Date:

2023-05-25

IPO Status:

Private

Industries: